139 related articles for article (PubMed ID: 28884595)
1. Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.
Lin SY; Lin CL; Chen HT; Kao CH
Curr Med Res Opin; 2018 May; 34(5):805-812. PubMed ID: 28884595
[TBL] [Abstract][Full Text] [Related]
2. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
3. Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea.
Suh B; Shin DW; Park Y; Lim H; Yun JM; Song SO; Park JH; Cho B; Guallar E
Eur J Endocrinol; 2019 Jan; 180(1):11-20. PubMed ID: 30400044
[TBL] [Abstract][Full Text] [Related]
4. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.
Kim MS; Lee JW; Hyun MK; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):288-299. PubMed ID: 38437824
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in patients with osteoporosis: a population-based cohort study.
Sun LM; Liang JA; Lin CL; Lin MC; Chang NJ; Kao CH
Curr Med Res Opin; 2017 Apr; 33(4):733-739. PubMed ID: 28044464
[TBL] [Abstract][Full Text] [Related]
6. Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study.
Wu CC; Yu YY; Yang HC; Nguyen PA; Poly TN; Islam MM; Iqbal U; Khan HAA; Wang YC; Cheng YT; Li YC; Jian WS
Arch Gynecol Obstet; 2018 Aug; 298(2):389-396. PubMed ID: 29961136
[TBL] [Abstract][Full Text] [Related]
7. Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study.
Lin CY; Lin CL; Huang WS; Kao CH
J Nucl Med; 2016 May; 57(5):685-90. PubMed ID: 26719377
[TBL] [Abstract][Full Text] [Related]
8. Is Partial or Total Thyroidectomy Associated with Risk of Long-Term Osteoporosis: A Nationwide Population-Based Study.
Hung CL; Yeh CC; Sung PS; Hung CJ; Muo CH; Sung FC; Jou IM; Tsai KJ
World J Surg; 2018 Sep; 42(9):2864-2871. PubMed ID: 29541822
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine treatment and occurrence of fracture of the hip.
Sheppard MC; Holder R; Franklyn JA
Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
[TBL] [Abstract][Full Text] [Related]
10. Risk of cancer in long-term levothyroxine users: Retrospective population-based study.
Wu CC; Islam MM; Nguyen PA; Poly TN; Wang CH; Iqbal U; Li YJ; Yang HC
Cancer Sci; 2021 Jun; 112(6):2533-2541. PubMed ID: 33793038
[TBL] [Abstract][Full Text] [Related]
11. Increased Risk of Type 2 Diabetes in Patients With Thyroid Cancer After Thyroidectomy: A Nationwide Cohort Study.
Roh E; Noh E; Hwang SY; Kim JA; Song E; Park M; Choi KM; Baik SH; Cho GJ; Yoo HJ
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1047-e1056. PubMed ID: 34718625
[TBL] [Abstract][Full Text] [Related]
12. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
Do Cao C; Wémeau JL
Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
[TBL] [Abstract][Full Text] [Related]
13. Risk of osteoporosis and pathologic fractures in cancer patients who underwent hematopoietic stem cell transplantation: a nationwide retrospective cohort study.
Lin JN; Chen HJ; Yang CH; Lai CH; Lin HH; Chang CS; Liang JA
Oncotarget; 2017 May; 8(21):34811-34819. PubMed ID: 28422731
[TBL] [Abstract][Full Text] [Related]
14. Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women.
Ko YJ; Kim JY; Lee J; Song HJ; Kim JY; Choi NK; Park BJ
J Prev Med Public Health; 2014 Jan; 47(1):36-46. PubMed ID: 24570805
[TBL] [Abstract][Full Text] [Related]
15. Sleep disorders increase the risk of osteoporosis: a nationwide population-based cohort study.
Yen CM; Kuo CL; Lin MC; Lee CF; Lin KY; Lin CL; Chang SN; Sung FC; Kao CH
Sleep Med; 2014 Nov; 15(11):1339-44. PubMed ID: 25224072
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
17. Association of sepsis with risk for osteoporosis: a population-based cohort study.
Lee YF; Tsou HK; Leong PY; Wang YH; Wei JC
Osteoporos Int; 2021 Feb; 32(2):301-309. PubMed ID: 32827276
[TBL] [Abstract][Full Text] [Related]
18. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
19. Women with alopecia exhibit a higher risk for thyroid cancer: a nationwide cohort study.
Sun LM; Lin MC; Muo CH; Liang JA; Sung FC; Kao CH
J Dermatol Sci; 2014 Apr; 74(1):18-22. PubMed ID: 24439037
[TBL] [Abstract][Full Text] [Related]
20. Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.
Kok VC; Horng JT; Wang MN; Chen ZY; Kuo JT; Hung GD
Osteoporos Int; 2018 Apr; 29(4):973-985. PubMed ID: 29383389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
